SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., July 19. 12, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative, patient-focused, commercial-stage global biopharmaceutical company, today announced that it will report financial results and company update for the three months ended June 30, 2022, following the close of U.S. stock markets on August 9, 2022. The Company will host a live conference call and webcast on August 10, 2022, at 8:00 a.m. ET.
Conference Call and Webcast Information
Listeners can access the live webcast by visiting the Company’s website at http://ir.zailaboratory.com. Participants must register before the conference call. The details are as follows:
Registration link: https://register.vevent.com/register/BI462e47de1af64af599432ab5c90a148b
All attendees should use the link provided above to complete the online registration process prior to the conference call. Upon registration, each participant will receive a dial-in number, a live event access code and a unique access PIN, which can be used to join the conference call.
A replay will be available shortly after the call and can be viewed by visiting the company’s website at http://ir.zailaboratory.com.
About Zai Lab
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States, focused on delivering transformative medicines for the oncology, autoimmune diseases, infectious diseases and neurological disorders. patients in China and around the world. Our goal is to leverage our skills and resources to positively impact human health around the world.
For more information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us on www.twitter.com/ZaiLab_Global.
For more information please contact:
Investor Relations: Lina Zhang
+86 136 8257 6943
Media: Danielle Halstrom / Xiaoyu Chen
+1 (215) 280-3898 / +86 185 0015 5011
Source: Zai Lab Limited
Copyright 2022 GlobeNewswire, Inc.